Pretzel Therapeutics Answers Key Questions from the POLG Community
Following the POLG Foundation Summit, Pretzel Therapeutics has shared updated answers to community questions about PX578, their first‑in‑class investigational therapy for […]
POLG
A Major Step Forward for the Global POLG Community
FDA clears PX578 to enter Phase 2 clinical testing At IMP, few moments bring more hope than seeing innovative science